This study is a multicenter, prospective registration study that will follow up patients with clinically confirmed and suspected amyotrophic lateral sclerosis for a period of 2 years. A total of 1000 patients will be included to dynamically observe the changes in clinical symptoms and signs, imaging, electrophysiology, biomarkers, biological samples and so on, which will construct a genetic profile of ALS in China, explore the etiology and pathogenesis, and establish an iPSCs library, provide a basis for finding treatment targets.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years old ≤ age ≤ 80 years old;
Patients are diagnosed definite or probable ALS according to the Awaji diagnostic criteria;
Sign an informed consent form.
You may not be if
Unable to cooperate with research or complete follow-up due to geographical or other reasons.